Wenhao Xia

Wenhao Xia currently serves as the Manager of In Vivo Study Operations at Vectura Fertin Pharma Laboratories, overseeing a team responsible for delivering regulatory toxicological studies in compliance with GLP standards. Prior roles include Senior Scientist in Study Management at Vectura Fertin Pharma Laboratories, where in vivo pharmacology and toxicology support were provided, and Senior Scientist at GSK, leading ex-vivo/in-vivo screening activities for a lead optimization program. Wenhao began as a Research Scientist at Takeda Singapore Pte Ltd, contributing histology support to drug discovery programs, and previously completed a PhD in Neuroscience at the National University of Singapore, focusing on oligodendrocyte biology. Academic credentials also include a Bachelor's degree in Life Science from the National University of Singapore.